Literature DB >> 20198305

Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met.

Ke-Min Cai1, Xue-Li Bao, Xu-Hui Kong, Wu Jinag, Ming-Rong Mao, Jiu-Sheng Chu, Yong-Jiu Huang, Xiao-Jun Zhao.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNA molecules that negatively modulate gene expression at the post-transcriptional level. A growing number of studies has shown that more and more miRNAs are aberrantly expressed and involved in the pathogenesis of several types of cancers. Here, we report that the down-regulated hsa-miR-34c was also involved in oncogenesis of laryngeal carcinoma. Our studies indicated that hsa-miR-34c functioned as a tumor suppressor which inhibited growth and invasion of human laryngeal carcinoma cells. Furthermore, in our study, an inverse relationship between the expression of hsa-miR-34c and c-Met was identified in 10 paired fresh samples from tumor tissues and adjacent normal tissues. Infection of hsa-miR-34c mediated by lentivirus suppressed the expression of c-Met directly. In addition, introduction of c-Met cDNA lacking 3'-UTR largely abrogated hsa-miR-34c-induced cell growth and invasion inhibition. These findings suggest aberrantly down-regulated hsa-miR-34c is a critical factor that contributes to malignancy in human laryngeal carcinoma by a mechanism involving targeting of c-Met.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198305     DOI: 10.3892/ijmm_00000378

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  28 in total

1.  MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells.

Authors:  Fengyan Yu; Yu Jiao; Yinghua Zhu; Ying Wang; Jingde Zhu; Xiuying Cui; Yujie Liu; Yinghua He; Eun-Young Park; Hongyu Zhang; Xiaobin Lv; Kelong Ma; Fengxi Su; Jong Hoon Park; Erwei Song
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

2.  Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.

Authors:  Na Shen; Xinsheng Huang; Jun Li
Journal:  Tumour Biol       Date:  2015-08-29

3.  MicroRNA-10a-5p and microRNA-34c-5p in laryngeal epithelial premalignant lesions: differential expression and clinicopathological correlation.

Authors:  Yanping Hu; Honggang Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-30       Impact factor: 2.503

Review 4.  The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials.

Authors:  Andreas Varkaris; Paul G Corn; Sanchaika Gaur; Farshid Dayyani; Christopher J Logothetis; Gary E Gallick
Journal:  Expert Opin Investig Drugs       Date:  2011-10-28       Impact factor: 6.206

5.  MicroRNA-34c targets TGFB-induced factor homeobox 2, represses cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Yan Wang; Chun-Mei Wang; Zhen-Zhong Jiang; Xiao-Jian Yu; Chun-Guang Fan; Fei-Fei Xu; Qing Zhang; L I Li; Rui-Feng Li; Wen-Sheng Sun; Zhen-Hai Zhang; Yu-Gang Liu
Journal:  Oncol Lett       Date:  2015-08-27       Impact factor: 2.967

Review 6.  MicroRNAs in the p53 network: micromanagement of tumour suppression.

Authors:  Heiko Hermeking
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

7.  miRNA-34c inhibits myoblasts proliferation by targeting YY1.

Authors:  Meng Wang; Chuncheng Liu; Yang Su; Kuo Zhang; Yuying Zhang; Min Chen; Mengxu Ge; Lijie Gu; Tianyu Lu; Ning Li; Zhengquan Yu; Qingyong Meng
Journal:  Cell Cycle       Date:  2017-01-26       Impact factor: 4.534

8.  Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis.

Authors:  Lei Wang; Jeffrey Ho; Carlotta Glackin; Manuela Martins-Green
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

Review 9.  MicroRNAs in laryngeal cancer: implications for diagnosis, prognosis and therapy.

Authors:  Pei Li; Hui Liu; Zhiyuan Wang; Feng He; Haifeng Wang; Zhi Shi; Ankui Yang; Jin Ye
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

10.  KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells.

Authors:  Shu Yang; Wen-shuai Li; Fang Dong; Hai-mei Sun; Bo Wu; Jun Tan; Wan-jing Zou; De-shan Zhou
Journal:  J Cell Mol Med       Date:  2014-09-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.